| Code | CSB-RA023994MB5HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is designed as a research-grade biosimilar to OX118, targeting TNFSF4 (Tumor Necrosis Factor Superfamily Member 4), also known as OX40 ligand (OX40L) or CD252. TNFSF4 is a type II transmembrane protein primarily expressed on activated antigen-presenting cells, including dendritic cells, B cells, and macrophages. It functions as a critical costimulatory molecule in T cell activation and differentiation by binding to its receptor OX40 (CD134) on activated T cells. This interaction plays essential roles in regulating immune responses, promoting T cell survival, proliferation, and cytokine production. Dysregulation of the OX40-OX40L pathway has been implicated in various immunological disorders, including autoimmune diseases, allergic inflammation, and cancer, making it an important therapeutic target.
OX118 is a well-established research tool originally developed for investigating TNFSF4 biology and immune regulation. This biosimilar antibody provides researchers with a reliable reagent for studying OX40L-mediated immune mechanisms, T cell costimulation pathways, and potential immunotherapeutic strategies in preclinical models.
There are currently no reviews for this product.